No Data
No Data
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Earnings Week Ahead: MSFT, AAPL, META, AMZN, QCOM, PFE, MA, V, PYPL, ROKU, MCD, SBUX, KO, and More
Bausch Health Announces Launch of Solta Medical's Fraxel FTX
Earnings Preview: BHC to Report Financial Results Post-market on April 30
Bausch + Lomb Spikes on Plans to Relaunch EnVista Lenses Following Recall
Bausch + Lomb Up 5.2% In US Premarket As Returns Intraocular Lenses to Market Following Voluntary Recall
73164454 : Staying away from China Stocks is not an issue with any company, but rather due to uncertainty.
105742796 Learner : Stock volatility
New plans new forecast
Revenue release
SPICYDOC辣刀客 73164454 : IS there any certainty with any stocks unless insider information? Two things certain about Chinese stocks are low valuation, and determination to bottom up with government support.
Laine Ford : I say no more talk to yall now